- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00873847
Cerebral Function Monitoring in Premature Infants
Cerebral Function Monitoring and Brain Injury in Preterm Infants: Correlation With Neuroimaging Abnormalities and Neurodevelopmental Impairment - a Pilot Study
Studieoversigt
Status
Detaljeret beskrivelse
Few techniques exist to permit early and accurate prognosis of brain injury in newborns. Cranial ultrasound and magnetic resonance imaging (MRI) have been used to detect structural abnormalities which may be useful in predicting neuromotor and neurocognitive deficits. However, up to 30% of extremely low birth weight infants with normal ultrasounds have adverse outcomes, and MRI is not feasible when an infant is critically ill. Amplitude-integrated electroencephalogram (aEEG) is a non-invasive, bedside instrument which allows real-time monitoring of brain function and may provide additional information for predicting outcomes in extremely premature infants.
This observational study will enroll 85-100 infants between 401-1,000 grams birth weight OR between 23 0/7 and 28 6/7 weeks gestational age born at the 7 participating NICHD Neonatal Research Network sites. Eligible infants will undergo an aEEG recording in the first 72 hours of life, a second aEEG recording between 72-168 hours of life, and weekly thereafter up to 36 weeks post-menstrual age.
The study tests the feasibility of enrolling subjects and obtaining the required aEEG recordings. The information gathered will provide a framework for the design of a potential prospective, observational, multi-center study for prediction of death or neurodevelopmental impairment by 18-22 months of age.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
California
-
Palo Alto, California, Forenede Stater, 94304
- Stanford University
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater, 30303
- Emory University
-
-
Michigan
-
Detroit, Michigan, Forenede Stater, 48201
- Wayne State University
-
-
North Carolina
-
Durham, North Carolina, Forenede Stater, 27710
- Duke University
-
Durham, North Carolina, Forenede Stater, 27705
- RTI International
-
-
Rhode Island
-
Providence, Rhode Island, Forenede Stater, 02905
- Brown University, Women & Infants Hospital of Rhode Island
-
-
Texas
-
Dallas, Texas, Forenede Stater, 75235
- University of Texas Southwestern Medical Center at Dallas
-
Houston, Texas, Forenede Stater, 77030
- University of Texas Health Science Center at Houston
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Inborn infants
- Between 401 grams and 1,000 grams inclusive birth weight OR between 23 0/7 and 28 6/7 weeks inclusive gestational age
- Decision to provide full intensive care support
- Less than 72 hours of age
Exclusion Criteria:
- Non-intact skin at the central or parietal regions of scalp
- Presence of known or suspected congenital anomalies, including:
- Congenital central nervous system malformations
- Chromosomal anomalies or multiple congenital anomalies
- Complex congenital heart disease
- Inborn error of metabolism
- Acidosis (pH < 6.8 for > 2 hours)
- Persistent bradycardia [HR < 100 bpm] associated with hypoxia for > 2 hours
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
First aEEG within 72 hours of age
Tidsramme: < 72 hours of age
|
< 72 hours of age
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Time required by research personnel to conduct study activities
Tidsramme: Birth to 36 weeks post menstrual age
|
Birth to 36 weeks post menstrual age
|
|
Serious adverse events
Tidsramme: < 72 hours of age until 36 weeks post menstrual age
|
< 72 hours of age until 36 weeks post menstrual age
|
|
Agreement between aEEG recordings and clinical events including: seizures, cardiopulmonary resuscitation, surfactant administration, suctioning, and intubation
Tidsramme: < 72 hours of age until 36 weeks post menstrual age
|
< 72 hours of age until 36 weeks post menstrual age
|
|
Weekly aEEG until infant is 36 weeks post menstrual age
Tidsramme: < 72 hours of age until 36 weeks post menstrual age
|
< 72 hours of age until 36 weeks post menstrual age
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Ricki F. Goldstein, MD, Duke University
- Ledende efterforsker: Alexis Davis, MD, Stanford University
- Ledende efterforsker: Lina Chalak, MD, University of Texas, Southwestern Medical Center at Dallas
Publikationer og nyttige links
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- NICHD-NRN-0042
- U10HD021373 (U.S. NIH-bevilling/kontrakt)
- U10HD021385 (U.S. NIH-bevilling/kontrakt)
- U10HD027851 (U.S. NIH-bevilling/kontrakt)
- U10HD027880 (U.S. NIH-bevilling/kontrakt)
- U10HD027904 (U.S. NIH-bevilling/kontrakt)
- U10HD040492 (U.S. NIH-bevilling/kontrakt)
- U10HD040689 (U.S. NIH-bevilling/kontrakt)
- UL1RR025744 (U.S. NIH-bevilling/kontrakt)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .